PETX– Aratana Therepeutics Inc is a pet therapeutics company which manufactures and distributes bio pharmaceutical products for pets. The stock rose 5% during after-hours yesterday.
PETX- Aratana Therepeutics Inc
|Fundamentals||Previously closed at||5.19|
|Analysts opinion||PETX has been granted its first FDA approval for Galliprant which controls the pain and inflammation with Osteoarthritis in dogs. Analysts have a consensus target price of $11.83 for the stock. The shares surged intraday upto its resistance at $6.17 and closed at 5.19. If the resistance levels are crossed, the stock may see a share price of $10.|
|Sentiments||Due to the news, the stock rose 5% yesterday and is expected to be bullish.|
|Social Media Pulse||The stock has 100% higher chatter than usual.|
ESLT – Elbit Systems Ltd is an Israel-based defense, homeland security and commercial aviation company.
ESLT – Elbit Systems Ltd
|Fundamentals||Previously closed at||90.26|
|Analyst opinion||ESLT reported its Q4 and FY2015 earnings today. For Q4, it reported revenues of $886.6 Million, compared $850.3 million in the Prior Year Q4. It reported a GAAP gross profit of $253.3 million for Q4. Revenues for FY 2015 saw a rise, at $3107.6 million with a profit of $897.1 million.|
|Sentiments||The news is expected to have strong positive impact on the stock price. Sentiments are expected to be bullish for the stock today.|
|Social Media Pulse||The stock has 100% higher social chatter than usual.|
Disclaimer: This blog contains an aggregated view of analysts and opinions by the author. Do not consider this as financial advice. See http://stockal.com/legalities/